Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc. is an innovative biotechnology firm specializing in oncolytic virus technology to create localized therapies that effectively target cancerous cells while safeguarding healthy tissue. Focused on boosting anti-tumor immunity, Candel's robust pipeline offers solutions for a range of challenging malignancies, reflecting its commitment to overcoming treatment obstacles in oncology. Backed by a comprehensive intellectual property portfolio and strategic collaborations with prominent research institutions, Candel is well-positioned to lead transformative developments in cancer care, ultimately enhancing patient outcomes and advancing the field of oncology.